TW200640910A - Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors - Google Patents
Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptorsInfo
- Publication number
- TW200640910A TW200640910A TW095105989A TW95105989A TW200640910A TW 200640910 A TW200640910 A TW 200640910A TW 095105989 A TW095105989 A TW 095105989A TW 95105989 A TW95105989 A TW 95105989A TW 200640910 A TW200640910 A TW 200640910A
- Authority
- TW
- Taiwan
- Prior art keywords
- compounds
- treatment
- methods
- inhibitors
- compound
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- ZGABDPXDUGYGQE-UHFFFAOYSA-N 1-piperidin-1-ylpiperazine Chemical class C1CCCCN1N1CCNCC1 ZGABDPXDUGYGQE-UHFFFAOYSA-N 0.000 title 1
- 102000009410 Chemokine receptor Human genes 0.000 title 1
- 108050000299 Chemokine receptor Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 7
- 238000000034 method Methods 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 abstract 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 abstract 1
- 102000004274 CCR5 Receptors Human genes 0.000 abstract 1
- 108010017088 CCR5 Receptors Proteins 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65557205P | 2005-02-23 | 2005-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200640910A true TW200640910A (en) | 2006-12-01 |
Family
ID=36540289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095105989A TW200640910A (en) | 2005-02-23 | 2006-02-22 | Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7659275B2 (zh) |
| EP (1) | EP1858887A1 (zh) |
| JP (1) | JP4769257B2 (zh) |
| KR (1) | KR20070107085A (zh) |
| CN (1) | CN101163695A (zh) |
| AR (1) | AR054740A1 (zh) |
| AU (1) | AU2006216731A1 (zh) |
| BR (1) | BRPI0609251A2 (zh) |
| CA (1) | CA2598651A1 (zh) |
| IL (1) | IL185395A0 (zh) |
| MX (1) | MX2007010258A (zh) |
| NO (1) | NO20074825L (zh) |
| PE (1) | PE20061012A1 (zh) |
| RU (1) | RU2411241C2 (zh) |
| TW (1) | TW200640910A (zh) |
| WO (1) | WO2006091692A1 (zh) |
| ZA (1) | ZA200707019B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU229709B1 (en) | 2004-04-13 | 2014-05-28 | Incyte Corp Wilmington | Piperazinyilpiperidine derivatives as chemokine receptor antagonists |
| KR100861024B1 (ko) * | 2007-07-20 | 2008-09-30 | 세크론 주식회사 | 반도체 제조 장치 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA01011116A (es) * | 1999-05-04 | 2002-06-04 | Schering Corp | Terapia de hiv de combinacion de antagonista ccr5 - interferon alfa pegilado. |
| RU2299206C9 (ru) * | 1999-05-04 | 2007-11-20 | Шеринг Корпорейшн | Производные пиперазина, фармацевтические композиции, их содержащие, и применение в качестве антагонистов ccr5 |
| US6689765B2 (en) * | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
| US6391865B1 (en) * | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
| US6387930B1 (en) * | 1999-05-04 | 2002-05-14 | Schering Corporation | Piperidine derivatives useful as CCR5 antagonists |
| AR033517A1 (es) * | 2000-04-08 | 2003-12-26 | Astrazeneca Ab | Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos |
| PL364560A1 (en) * | 2001-03-29 | 2004-12-13 | Schering Corporation | Ccr5 antagonists useful for treating aids |
| IL157713A0 (en) * | 2001-03-29 | 2004-03-28 | Schering Corp | Aryl oxime-piperazines useful as ccr5 antagonists |
| GB0223223D0 (en) * | 2002-10-07 | 2002-11-13 | Novartis Ag | Organic compounds |
| PE20040769A1 (es) | 2002-12-18 | 2004-11-06 | Schering Corp | Derivados de piperidina utiles como antagonisas ccr5 |
| JO2525B1 (en) * | 2004-04-08 | 2010-03-17 | شركة جانسين فارماسوتيكا ان. في | Derived 4-alkyl-and-4-canoelperidine derivatives and their use as anti-neroquin |
-
2006
- 2006-02-21 AR ARP060100621A patent/AR054740A1/es not_active Application Discontinuation
- 2006-02-21 JP JP2007557135A patent/JP4769257B2/ja not_active Expired - Fee Related
- 2006-02-21 BR BRPI0609251-9A patent/BRPI0609251A2/pt not_active IP Right Cessation
- 2006-02-21 KR KR1020077019808A patent/KR20070107085A/ko not_active Application Discontinuation
- 2006-02-21 AU AU2006216731A patent/AU2006216731A1/en not_active Abandoned
- 2006-02-21 EP EP06735837A patent/EP1858887A1/en not_active Withdrawn
- 2006-02-21 RU RU2007135126/04A patent/RU2411241C2/ru not_active IP Right Cessation
- 2006-02-21 CA CA002598651A patent/CA2598651A1/en not_active Abandoned
- 2006-02-21 CN CNA2006800137690A patent/CN101163695A/zh active Pending
- 2006-02-21 WO PCT/US2006/006333 patent/WO2006091692A1/en active Application Filing
- 2006-02-21 PE PE2006000210A patent/PE20061012A1/es not_active Application Discontinuation
- 2006-02-21 US US11/358,520 patent/US7659275B2/en not_active Expired - Fee Related
- 2006-02-21 MX MX2007010258A patent/MX2007010258A/es unknown
- 2006-02-22 TW TW095105989A patent/TW200640910A/zh unknown
-
2007
- 2007-08-20 IL IL185395A patent/IL185395A0/en unknown
- 2007-08-21 ZA ZA200707019A patent/ZA200707019B/xx unknown
- 2007-09-21 NO NO20074825A patent/NO20074825L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20061012A1 (es) | 2006-10-03 |
| EP1858887A1 (en) | 2007-11-28 |
| US20060223821A1 (en) | 2006-10-05 |
| NO20074825L (no) | 2007-10-17 |
| MX2007010258A (es) | 2007-09-11 |
| WO2006091692A1 (en) | 2006-08-31 |
| AU2006216731A1 (en) | 2006-08-31 |
| CN101163695A (zh) | 2008-04-16 |
| RU2007135126A (ru) | 2009-03-27 |
| US7659275B2 (en) | 2010-02-09 |
| JP4769257B2 (ja) | 2011-09-07 |
| JP2008531575A (ja) | 2008-08-14 |
| AR054740A1 (es) | 2007-07-11 |
| CA2598651A1 (en) | 2006-08-31 |
| BRPI0609251A2 (pt) | 2010-03-09 |
| IL185395A0 (en) | 2008-02-09 |
| ZA200707019B (en) | 2008-10-29 |
| RU2411241C2 (ru) | 2011-02-10 |
| KR20070107085A (ko) | 2007-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04001886A (es) | Derivados de piperidina utiles como antagonistas de ccr5. | |
| AR057873A2 (es) | Compuestos derivados de piperizina utiles como antagonistas ccr5, composiciones farmaceuticas que los comprenden, y el uso de los mismos para la preparacion de medicamentos | |
| MX2010005292A (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana. | |
| MX2012004020A (es) | Analogos de heterociclilo pirazolopirimidina como inhibidores de jak. | |
| MX2007014619A (es) | Pirrolopiridinas de utilidad como inhibidores de proteina quinasa. | |
| WO2007113841A3 (en) | Novel aminoglycosides and uses thereof in the treatment of genetic disorders | |
| EA200802203A1 (ru) | Дикетопиперазиновые и пиперидиновые производные в качестве противовирусных агентов | |
| EP3363797A8 (en) | Oral dosage form of apoptosis signal-regulating kinase inhibitors | |
| GB0625648D0 (en) | Compounds | |
| NO20073101L (no) | Nye pyridinforbindelser | |
| NO20070445L (no) | Pyrimidinderivater. | |
| RS101304A (sr) | Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi | |
| WO2010142766A3 (en) | Pyrimidine derivatives as zap-70 inhibitors | |
| NO20090327L (no) | Nye forbindelser 384 | |
| TW200745136A (en) | 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives | |
| TW200726758A (en) | New pyridine analogues | |
| ATE462703T1 (de) | Bicyclononen-derivate als renin-inhibitoren | |
| NO20071399L (no) | VLA-4-antagonister | |
| TW200716616A (en) | Modulators of CCR-5 activity | |
| NO20082297L (no) | Piperazinderivater som er anvendelige som CCR5-antagonister | |
| WO2005042517A3 (en) | Bipiperidinyl derivatives useful as inhibitors of chemokine receptors | |
| TW200745087A (en) | CCR5 antagonists useful for treating HIV | |
| TW200640910A (en) | Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors | |
| MY147899A (en) | Piperidine derivatives useful as ccr5 antagonists | |
| GB0407025D0 (en) | Novel compounds |